Jasper Therapeutics (JSPR) PT Lowered to $20 at Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Gavin Clark-Gartner lowered the price target on Jasper Therapeutics (NASDAQ: JSPR) to $20.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
